These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 11297518

  • 1. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.
    Xie D, Miller CW, O'Kelly J, Nakachi K, Sakashita A, Said JW, Gornbein J, Koeffler HP.
    J Biol Chem; 2001 Apr 27; 276(17):14187-94. PubMed ID: 11297518
    [Abstract] [Full Text] [Related]

  • 2. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS, Bogart DF, Li P, Mehmi I, Lupu R.
    Oncogene; 2002 Jan 31; 21(6):964-73. PubMed ID: 11840342
    [Abstract] [Full Text] [Related]

  • 3. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
    Sampath D, Winneker RC, Zhang Z.
    Endocrinology; 2001 Jun 31; 142(6):2540-8. PubMed ID: 11356703
    [Abstract] [Full Text] [Related]

  • 4. Cyr61 promotes breast tumorigenesis and cancer progression.
    Tsai MS, Bogart DF, Castañeda JM, Li P, Lupu R.
    Oncogene; 2002 Nov 21; 21(53):8178-85. PubMed ID: 12444554
    [Abstract] [Full Text] [Related]

  • 5. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
    Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP.
    Cancer Res; 2001 Dec 15; 61(24):8917-23. PubMed ID: 11751417
    [Abstract] [Full Text] [Related]

  • 6. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.
    Banerjee S, Saxena N, Sengupta K, Tawfik O, Mayo MS, Banerjee SK.
    Neoplasia; 2003 Dec 15; 5(1):63-73. PubMed ID: 12659671
    [Abstract] [Full Text] [Related]

  • 7. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.
    Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP.
    J Biol Chem; 2001 Dec 14; 276(50):47709-14. PubMed ID: 11598125
    [Abstract] [Full Text] [Related]

  • 8. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
    Fritah A, Redeuilh G, Sabbah M.
    J Endocrinol; 2006 Dec 14; 191(3):613-24. PubMed ID: 17170219
    [Abstract] [Full Text] [Related]

  • 9. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.
    Tsai MS, Hornby AE, Lakins J, Lupu R.
    Cancer Res; 2000 Oct 15; 60(20):5603-7. PubMed ID: 11059746
    [Abstract] [Full Text] [Related]

  • 10. Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.
    Kannan N, Kang J, Kong X, Tang J, Perry JK, Mohankumar KM, Miller LD, Liu ET, Mertani HC, Zhu T, Grandison PM, Liu DX, Lobie PE.
    Neoplasia; 2010 Dec 15; 12(12):1041-53. PubMed ID: 21170268
    [Abstract] [Full Text] [Related]

  • 11. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.
    Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, Kuo ML.
    J Biol Chem; 2004 Jun 04; 279(23):24015-23. PubMed ID: 15044484
    [Abstract] [Full Text] [Related]

  • 12. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
    Osipo C, Meeke K, Cheng D, Weichel A, Bertucci A, Liu H, Jordan VC.
    Int J Oncol; 2007 Feb 04; 30(2):509-20. PubMed ID: 17203234
    [Abstract] [Full Text] [Related]

  • 13. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB.
    Oncogene; 2002 Jun 06; 21(25):4000-8. PubMed ID: 12037682
    [Abstract] [Full Text] [Related]

  • 14. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.
    Babic AM, Kireeva ML, Kolesnikova TV, Lau LF.
    Proc Natl Acad Sci U S A; 1998 May 26; 95(11):6355-60. PubMed ID: 9600969
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J, Kitlen JW, Briand P, Labrie F, Lykkesfeldt AE.
    J Steroid Biochem Mol Biol; 2003 Mar 26; 84(4):469-78. PubMed ID: 12732292
    [Abstract] [Full Text] [Related]

  • 19. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
    Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J, Lupu R.
    Oncol Rep; 2000 Mar 26; 7(1):157-67. PubMed ID: 10601611
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP, Buteau-Lozano H, Herve MA, Corpet A.
    Adv Exp Med Biol; 2008 Mar 26; 617():437-44. PubMed ID: 18497067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.